- Home
- HTFL vs GOF Comparison
HTFL vs GOF Comparison
Compare HTFL & GOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | HTFL | GOF |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Finance/Investors Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 2025 | 2006 |
Fundamental Metrics
Financial Performance| Metric | HTFL | GOF |
|---|---|---|
| Price | $51.41 | $8.71 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $46.00 | N/A |
| AVG Volume (30 Days) | 1.4M | ★ 2.8M |
| Earning Date | 11-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 82.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $176,034,000.00 | N/A |
| Revenue This Year | $41.41 | N/A |
| Revenue Next Year | $24.15 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 39.92 | N/A |
| 52 Week Low | $20.13 | $8.40 |
| 52 Week High | $53.07 | $15.07 |
Technical Indicators
Market Signals| Indicator | HTFL | GOF |
|---|---|---|
| Relative Strength Index (RSI) | 61.93 | 39.20 |
| Support Level | $46.44 | $8.40 |
| Resistance Level | $51.73 | $10.74 |
| Average True Range (ATR) | 2.43 | 0.15 |
| MACD | -0.26 | 0.06 |
| Stochastic Oscillator | 64.53 | 76.83 |
Price Performance
Historical ComparisonAbout HTFL Heartflow Inc.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
About GOF Guggenheim Strategic Opportunities Fund of Beneficial Interest
Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The Fund's investment objective is to maximize total return through a combination of current income and capital appreciation. It has single operating segment. Its products are Mutual Funds, Wealth Management SMAS, Institutional SMAS, ETFS, UITS, UCITS, CIT, Closed-End Funds, Private Funds, Rydex Funds, and Variable Insurance funds.